|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation expense | |||||
| Impairment of fixed assets | |||||
| Loss on the sale and disposal of fixed assets | |||||
| Non-cash stock compensation expense | |||||
| Non-cash lease expense | |||||
| Non-cash interest expense | |||||
| Change in fair value of warrant liabilities | |||||
| Accretion of debt discount | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred income | |||||
| Lease liability | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Purchase of fixed assets | |||||
| Proceeds from the sale of fixed assets | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from term loan, net of issuance costs | |||||
| Proceeds from issuance of common stock in registered direct offering, net of issuance costs | |||||
| Proceeds from option exercises | |||||
| Proceeds from issuance of common stock and accompanying pre-funded warrants in public offering, net of issuance costs | |||||
| Principal payments on term loan payable to a bank | |||||
| Payments related to tax withholding for vested restricted stock units | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental disclosures of non-cash information: | |||||
| Change in right of use asset and lease liability due to lease amendment | |||||
| Initial fair value of warrant liability in connection with debt financing | |||||
| Capital expenditures in accounts payable and accrued expenses | |||||
| Deferred offering issuance costs in accounts payable and accrued expenses | |||||
Loading...